Does AMBRISENTAN Cause Lung neoplasm malignant? 155 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 155 reports of Lung neoplasm malignant have been filed in association with AMBRISENTAN (AMBRISENTAN). This represents 0.2% of all adverse event reports for AMBRISENTAN.
155
Reports of Lung neoplasm malignant with AMBRISENTAN
0.2%
of all AMBRISENTAN reports
53
Deaths
66
Hospitalizations
How Dangerous Is Lung neoplasm malignant From AMBRISENTAN?
Of the 155 reports, 53 (34.2%) resulted in death, 66 (42.6%) required hospitalization, and 3 (1.9%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMBRISENTAN. However, 155 reports have been filed with the FAERS database.
What Other Side Effects Does AMBRISENTAN Cause?
Dyspnoea (13,367)
Death (7,497)
Headache (7,325)
Pneumonia (4,693)
Dizziness (4,561)
Fatigue (4,436)
Diarrhoea (4,312)
Nausea (3,986)
Fluid retention (3,927)
Malaise (3,839)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which AMBRISENTAN Alternatives Have Lower Lung neoplasm malignant Risk?
AMBRISENTAN vs AMBROSIA ARTEMISIIFOLIA POLLEN
AMBRISENTAN vs AMBROXOL
AMBRISENTAN vs AMDINOCILLIN PIVOXIL
AMBRISENTAN vs AMG-510
AMBRISENTAN vs AMIFAMPRIDINE